QIAGEN GENEREAD Trademark

Trademark Overview


On Friday, July 12, 2013, a trademark application was filed for QIAGEN GENEREAD with the United States Patent and Trademark Office. The USPTO has given the QIAGEN GENEREAD trademark a serial number of 79136407. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Tuesday, July 11, 2023. This trademark is owned by Qiagen GmbH. The QIAGEN GENEREAD trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Products & Electrical & Scientific Products categories with the following description:

Computer software for use in scientific and medical research for assisting in analyzing and sequencing biomolecules, namely, nucleic acids

Diagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in pa...

Chemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical chemical reagents, enzymes and chemicals solutions in the nature of buffer solutions for scientific and/or medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals for laboratory or research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and ...
qiagen generead

General Information


Serial Number79136407
Word MarkQIAGEN GENEREAD
Filing DateFriday, July 12, 2013
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateTuesday, July 11, 2023
Registration Number4824206
Registration DateTuesday, October 6, 2015
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements


Goods and ServicesComputer software for use in scientific and medical research for assisting in analyzing and sequencing biomolecules, namely, nucleic acids
Goods and ServicesDiagnostic preparations for medical purposes; diagnostic preparations for veterinary purposes; diagnostic preparations for humans for medical purposes; preparations for medical and veterinary purposes, namely, diagnostic preparations, for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; chemical, biochemical and biotechnological preparations for medical and veterinary purposes, namely, diagnostic reagents, enzymes and diagnostic reagents in the nature of buffer solutions for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits containing preparations for medical and veterinary diagnostic purposes primarily consisting of diagnostic preparations for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
Goods and ServicesChemical, biochemical and biotechnological products for industrial and scientific purposes, namely, diagnostic preparations except for human or veterinary medical purposes, non-medical chemical reagents, enzymes and chemicals solutions in the nature of buffer solutions for scientific and/or medical research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing; kits comprising chemicals for laboratory or research use for sample preparation, modification and manipulation of cells and for marking, separating, isolating, purifying, duplicating, sequencing and/or for the analysis of biopolymers, in particular nucleic acids, proteins, macromolecules and biologically active substances, in particular nucleic acids of biological or biochemical sample material, in particular comprising chemicals for reagents, enzymes and buffer solutions for nucleic acid purification, enrichment, amplification and sequencing
Translation of Words in MarkThe word(s) "GENEREAD" has no meaning in a foreign language.

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, July 11, 2023
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, July 11, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes021, 023, 026, 036, 038
Class Status CodeH - NOT AVAILABLE
Class Status DateTuesday, July 11, 2023
Primary Code009
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameQiagen GmbH
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressHilden 40724
DE

Party NameQiagen GmbH
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressDE

Party NameQiagen GmbH
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressDE

Trademark Events


Event DateEvent Description
Sunday, February 4, 2024NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Sunday, February 4, 2024DEATH OF INTERNATIONAL REGISTRATION
Wednesday, July 6, 2022NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Wednesday, July 6, 2022REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Tuesday, July 5, 2022CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, September 20, 2021TEAS SECTION 71 & 15 RECEIVED
Tuesday, October 6, 2020COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, October 18, 2018NEW REPRESENTATIVE AT IB RECEIVED
Friday, March 18, 2016FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, February 29, 2016FINAL DISPOSITION NOTICE SENT TO IB
Monday, February 29, 2016FINAL DISPOSITION PROCESSED
Wednesday, January 6, 2016FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 6, 2015REGISTERED-PRINCIPAL REGISTER
Tuesday, July 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Friday, July 17, 2015NOTIFICATION PROCESSED BY IB
Wednesday, July 1, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 1, 2015NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 16, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, June 16, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 16, 2015EXAMINER'S AMENDMENT ENTERED
Tuesday, June 16, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 16, 2015EXAMINERS AMENDMENT E-MAILED
Tuesday, June 16, 2015EXAMINERS AMENDMENT -WRITTEN
Friday, March 20, 2015NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, March 4, 2015NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 4, 2015NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Monday, December 29, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, November 18, 2014NOTIFICATION OF FINAL REFUSAL EMAILED
Tuesday, November 18, 2014FINAL REFUSAL E-MAILED
Tuesday, November 18, 2014FINAL REFUSAL WRITTEN
Tuesday, November 18, 2014ASSIGNED TO LIE
Friday, August 22, 2014NEW REPRESENTATIVE AT IB RECEIVED
Thursday, May 15, 2014NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, May 15, 2014LETTER OF SUSPENSION E-MAILED
Thursday, May 15, 2014SUSPENSION LETTER WRITTEN
Saturday, May 10, 2014TEAS/EMAIL CORRESPONDENCE ENTERED
Saturday, May 10, 2014CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, April 28, 2014ASSIGNED TO LIE
Wednesday, April 9, 2014TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, November 23, 2013REFUSAL PROCESSED BY IB
Friday, November 1, 2013NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, October 30, 2013REFUSAL PROCESSED BY MPU
Wednesday, October 30, 2013NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, October 29, 2013NON-FINAL ACTION WRITTEN
Friday, October 25, 2013ASSIGNED TO EXAMINER
Tuesday, October 15, 2013APPLICATION FILING RECEIPT MAILED
Thursday, October 10, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 3, 2013SN ASSIGNED FOR SECT 66A APPL FROM IB